Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
21
Number of overlapping holdings
6.1%
% of FHLC's 369 holdings also in MEDX
70.0%
% of MEDX's 30 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.2% | 16.4% | 10.2% |
|
ABBVIE INC | 5.2% | 8.2% | 5.2% |
|
JOHNSON & JOHNSON | 6.1% | 4.6% | 4.6% |
|
MERCK & CO. INC. | 5.0% | 4.2% | 4.2% |
|
AMGEN INC | 2.8% | 5.6% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 8.3% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
DANAHER CORP | 3.0% |
|
ABBOTT LABORATORIES | 2.9% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
|
ELEVANCE HEALTH INC | 1.9% |
|
STRYKER CORP | 1.8% |
|
BOSTON SCIENTIFIC CORP | 1.7% |
 |
MEDTRONIC PLC | 1.6% |
FHLC Underweight Relative to MEDX
|
ELI LILLY & CO | -6.1% |
 |
NOVARTIS AG-ADR | -5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.1% |
|
BRISTOL-MYERS SQUIBB CO | -4.5% |
|
ALKERMES PLC | -4.3% |
|
ALNYLAM PHARMACEUTICALS INC | -3.9% |
|
ABBVIE INC | -3.1% |
|
AMGEN INC | -2.8% |
|
CRISPR THERAPEUTICS AG | -2.8% |
|
IONIS PHARMACEUTICALS, INC. | -2.7% |